DNAprint Genomics (DNAG)

[worktoplay]

Ah, but toad...

That is NOT the case in the Biofrontera deal. All shares have equal voting rights, thus DNAPrint WILL have majority voting control upon payment of the $2.7 million.

Shares are often issued in different designations just so that the particular shares can be destinguished from a previous issue. What is important is the rights associated with the shares when they are issued. And in DNAPrint's case, their shares carry equal voting power, thus majority voting control.

If you could read you would know that...

Later,
W2P